Treatment with aurora kinase inhibitors also enhanced IFN-γ–induced PD-L1 expression in other human tumor cell lines, including A549, HCT116, and T24 (Supplemental Figure 2, A and B). The gene discussed is IFNG; the disease is neoplasm.